Our AI instantly delivers powerful, actionable diabetes insights from one of the world’s richest diabetes datasets.
ADA and dQ&A survey results reveal that COVID fears kept one in five people with diabetes away from the doctor during the pandemic.
Which diabetes groups lead or lag on COVID-19 shots? See dQ&A’s panel results from March 2021 and uncover barriers to higher coverage.
Our survey finds major pharmacies often fail people with diabetes, with wide NPS score gaps; Sam’s Club, Publix, Costco, and U.S. Medical Supply rank highest.
5,700 dQ&A community members share where they were diagnosed, first symptoms, and emotions—highlighting key differences between type 1 and type 2 journeys.
This study examines how income affects diabetes outcomes, finding lower-income adults with type 2 diabetes face higher rates of complications and depression.
Our research with the ADA shows that people with diabetes are much worse off under the COVID-19 pandemic, compared to the nation as a whole.
Part 2 of dQ&A’s CGM series digs into adoption barriers and the Ambulatory Glucose Profile, which can help people make sense of the data CGMs provide.
We asked patients about using—and endocrinologists about prescribing—a connected insulin pen.
